{"slug":"regulation","tag":"regulation","variants":["regulation"],"description":"No description yet","count":14,"kinds":{"person":14},"related":[{"slug":"leadership","tag":"leadership","shared":13},{"slug":"health-technology-assessment","tag":"health technology assessment","shared":4},{"slug":"government","tag":"government","shared":3},{"slug":"clinician-scientist","tag":"clinician-scientist","shared":2},{"slug":"australia","tag":"australia","shared":1},{"slug":"data-sharing","tag":"data sharing","shared":1},{"slug":"data-standards","tag":"data standards","shared":1},{"slug":"drug-approval","tag":"drug approval","shared":1},{"slug":"drug-development","tag":"drug development","shared":1},{"slug":"paediatric-oncology","tag":"paediatric oncology","shared":1}],"records":[{"id":"emer-cooke","kind":"person","name":"Emer Cooke","route":"/people/emer-cooke/","tldr":"Executive Director of the European Medicines Agency since November 2020, overseeing EU approval of cancer medicines."},{"id":"lawrence-tallon","kind":"person","name":"Lawrence Tallon","route":"/people/lawrence-tallon/","tldr":"Chief Executive of the UK Medicines and Healthcare products Regulatory Agency, the body that approves and monitors cancer medicines and devices in the UK."},{"id":"sonja-optendrenk","kind":"person","name":"Sonja Optendrenk","route":"/people/sonja-optendrenk/","tldr":"Impartial chair of Germany's Federal Joint Committee (G-BA), the body that decides which treatments statutory health insurance covers."},{"id":"thomas-kaiser","kind":"person","name":"Thomas Kaiser","route":"/people/thomas-kaiser/","tldr":"Physician who directs IQWiG, the German institute that produces the benefit assessments underpinning cancer drug pricing and coverage decisions."},{"id":"chris-decker","kind":"person","name":"Chris Decker","route":"/people/chris-decker/","tldr":"Leads CDISC, the non-profit that sets the clinical trial data standards required by FDA and PMDA, including oncology-specific therapeutic area guides."},{"id":"gilles-vassal","kind":"person","name":"Gilles Vassal","route":"/people/gilles-vassal/","tldr":"Gustave Roussy paediatric oncologist and past SIOPE president who leads its oncopolicy work and helped shape European paediatric medicines regulation."},{"id":"joseph-ross","kind":"person","name":"Joseph S. Ross","route":"/people/joseph-ross/","tldr":"Yale health policy researcher on the YODA Project leadership team, known for work on FDA regulation and trial transparency."},{"id":"yasuhiro-fujiwara","kind":"person","name":"Yasuhiro Fujiwara","route":"/people/yasuhiro-fujiwara/","tldr":"Medical oncologist who heads Japan's Pharmaceuticals and Medical Devices Agency, the national drug and device regulator."},{"id":"lionel-collet","kind":"person","name":"Lionel Collet","route":"/people/lionel-collet/","tldr":"Physician and former university president who chairs the Haute Autorité de Santé, France's health technology assessment and quality body."},{"id":"jean-lessi","kind":"person","name":"Jean Lessi","route":"/people/jean-lessi/","tldr":"Director General of the Haute Autorité de Santé, responsible for the agency's operations since January 2024."},{"id":"shalene-curtis-micallef","kind":"person","name":"Shalene Curtis-Micallef","route":"/people/shalene-curtis-micallef/","tldr":"Senior public servant who has led Health Canada as Deputy Minister since January 2026, after serving as Canada's Deputy Minister of Justice."},{"id":"anthony-lawler","kind":"person","name":"Anthony Lawler","route":"/people/anthony-lawler/","tldr":"Head of Australia's medicines and medical devices regulator, the body that approves cancer drugs for the Australian market."},{"id":"rajeev-singh-raghuvanshi","kind":"person","name":"Rajeev Singh Raghuvanshi","route":"/people/rajeev-singh-raghuvanshi/","tldr":"India's Drugs Controller General, who heads the Central Drugs Standard Control Organisation, the national regulator for medicines, medical devices and clinical trials."},{"id":"huang-guo","kind":"person","name":"Huang Guo","route":"/people/huang-guo/","tldr":"Commissioner of China's National Medical Products Administration, the regulator whose Center for Drug Evaluation reviews new cancer drugs for the Chinese market."}]}